Age-dependent regulation of synaptic connections by dopamine D2 receptors
- PMID: 24121738
- PMCID: PMC3832846
- DOI: 10.1038/nn.3542
Age-dependent regulation of synaptic connections by dopamine D2 receptors
Abstract
Dopamine D2 receptors (D2R) are G protein-coupled receptors that modulate synaptic transmission and are important for various brain functions, including learning and working memory. Abnormal D2R signaling has been implicated in psychiatric disorders such as schizophrenia. Here we report a new function of D2R in dendritic spine morphogenesis. Activation of D2R reduced spine number via GluN2B- and cAMP-dependent mechanisms in mice. Notably, this regulation occurred only during adolescence. During this period, D2R overactivation caused by mutations in the schizophrenia risk gene Dtnbp1 led to spine deficiency, dysconnectivity in the entorhinal-hippocampal circuit and impairment of spatial working memory. Notably, these defects could be ameliorated by D2R blockers administered during adolescence. Our findings suggest an age-dependent function of D2R in spine development, provide evidence that D2R dysfunction during adolescence impairs neuronal circuits and working memory, and indicate that adolescent interventions to prevent aberrant D2R activity protect against cognitive impairment.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Comment in
-
Adolescent dopamine slows spine maturation.Nat Neurosci. 2013 Nov;16(11):1514-6. doi: 10.1038/nn.3558. Nat Neurosci. 2013. PMID: 24165676 No abstract available.
Similar articles
-
Age-Dependent D1-D2 Receptor Coactivation in the Lateral Orbitofrontal Cortex Potentiates NMDA Receptors and Facilitates Cognitive Flexibility.Cereb Cortex. 2016 Dec;26(12):4524-4539. doi: 10.1093/cercor/bhv222. Epub 2015 Sep 23. Cereb Cortex. 2016. PMID: 26405054
-
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors.J Neurosci. 1997 Jun 15;17(12):4536-44. doi: 10.1523/JNEUROSCI.17-12-04536.1997. J Neurosci. 1997. PMID: 9169514 Free PMC article.
-
Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.J Neurosci. 2012 Jun 27;32(26):9023-34. doi: 10.1523/JNEUROSCI.0918-12.2012. J Neurosci. 2012. PMID: 22745501 Free PMC article.
-
Deletion of Glycogen Synthase Kinase-3β in D2 Receptor-Positive Neurons Ameliorates Cognitive Impairment via NMDA Receptor-Dependent Synaptic Plasticity.Biol Psychiatry. 2020 Apr 15;87(8):745-755. doi: 10.1016/j.biopsych.2019.10.025. Epub 2019 Nov 6. Biol Psychiatry. 2020. PMID: 31892408 Free PMC article.
-
Pharmacology of hallucinations: several mechanisms for one single symptom?Biomed Res Int. 2014;2014:307106. doi: 10.1155/2014/307106. Epub 2014 Jun 4. Biomed Res Int. 2014. PMID: 24991548 Free PMC article. Review.
Cited by
-
Paternal Aggression in Early-life Impairs the Spatial Memory and Passive Avoidance Learning in Adulthood of Male Rats: The Possible Role of DRD2.Basic Clin Neurosci. 2023 May-Jun;14(3):431-442. doi: 10.32598/bcn.2021.3464.1. Epub 2023 May 1. Basic Clin Neurosci. 2023. PMID: 38077181 Free PMC article.
-
Activation of the Hippocampal DRD2 Alleviates Neuroinflammation, Synaptic Plasticity Damage and Cognitive Impairment After Sleep Deprivation.Mol Neurobiol. 2023 Dec;60(12):7208-7221. doi: 10.1007/s12035-023-03514-5. Epub 2023 Aug 5. Mol Neurobiol. 2023. PMID: 37543530
-
Synaptic plasticity in schizophrenia pathophysiology.IBRO Neurosci Rep. 2023 Feb 4;14:244-252. doi: 10.1016/j.ibneur.2023.01.008. eCollection 2023 Jun. IBRO Neurosci Rep. 2023. PMID: 37388494 Free PMC article.
-
Synaptic plasticity in schizophrenia pathophysiology.IBRO Neurosci Rep. 2022 Oct 31;13:478-487. doi: 10.1016/j.ibneur.2022.10.008. eCollection 2022 Dec. IBRO Neurosci Rep. 2022. PMID: 36590092 Free PMC article.
-
Male DAT Val559 Mice Exhibit Compulsive Behavior under Devalued Reward Conditions Accompanied by Cellular and Pharmacological Changes.Cells. 2022 Dec 15;11(24):4059. doi: 10.3390/cells11244059. Cells. 2022. PMID: 36552823 Free PMC article.
References
-
- Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10:79–104. - PubMed
-
- Green MF. Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu Rev Clin Psychol. 2007;3:159–180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
